ACTION Cœur is an independent academic not for profit Academic Research Organization (ARO), acting for and promoting, on a national and international level, clinical research and prevention in the field of cardiovascular diseases.

Its prime mission is to make progress in the care and treatment of cardiovascular diseases, by leading reliable clinical trials the results of which directly impact and enhance the prognosis and well-being of patients.

À la une

Logo Réunion Scientifique

Réunion scientifique

Jeudi 1er juin 2017 Hôpital Pitié-Salpêtrière - Institut de Cardiologie 5e étage - amphithéâtre ADICARE 83 boulevard Vincent Auriol - 75013 PARIS Inscription gratuite obligatoire par retour mail à : contact@action-coeur.org Inscription Programme 15h45 : Accueil Le groupe...

Logo Colloquium

Colloquium Cœur et Rein

Jeudi 18 mai 2017 À partir de 17h45 Hôpital Pitié-Salpêtrière - Institut de Cardiologie 5e étage - amphithéâtre ADICARE 83 boulevard Vincent Auriol - 75013 PARIS Inscription gratuite obligatoirepar retour mail à : contact@action-coeur.org Inscription Programme 18h00...

The Fonds de Dotation ACTION is licensed to receive grants and donations, help us via the helloasso platform !

ACTION Group has a subvention trust (Fond de Dotation) created in 2013 to run academic trials and perform prevention actions for all citizens suffering or not from cardiovascular diseases.

Browse our website www.action-fonds.org

« You can support our research and cardiovascular prevention by making our actions known !
Many thanks to all. »
– Pr. Gilles MONTALESCOT
Président ACTION group

Follow us on Twitter

New trials

ALPHEUS

Target : Evaluate the impact of a loading dose of the new inhibitor P2Y12...

ATLANTIS

Target : Demonstrate the superiority of an anticoagulation strategy with Apixaban vs a standard...

EVA-G-TAVI

Target : Using the geriatric evaluation to predict mortality, functional prognosis and quality of...

ARAMIS

Target : Trial evaluating Anakinra versus placebo when treating acute myocarditis and evaluation of...

ANTARCTIC

Target : Multicenter, randomized and open trial evaluating the interest of a dose...

ATLANTIC

Target : International, multicenter, randomized trial evaluating the impact of using a loading...

AGENT

Target : Transfer of Serca2a gene AAV1 vector type (adeno-associated virus 1) for...

ALBATROSS

Target :: National, multicenter, randomized trial comparing a specific blockage of aldosterone added...

AMERICA

Target : National, multicenter trial, evaluating the impact of systematic detection of polyvascular...

ATOLL

Target : International, multicenter trial comparing the use of enoxaparine IV versus standard IV...

Recent publications

Key indicators

0

PATIENTS ADMITTED

every year with acute coronary syndrome in France. In total 300.000 patients per year are hospitalized for a coronary disease and 40.000 deaths are recorded resulting from this disease.

0

CLINICAL TRIALS

managed by ACTION Group either published or in progress.

0

FELLOW DOCTORS

actively participating in the design, the implementation, the enrolment and the patient follow-up of academic or non-academic trials managed by ACTION Group.

0

HOSPITAL CENTERS

active in our network of clinical trials and acting for the enrolment of patients in our national and international trials.